Showing results (351-360 of 370) with videos related to

Sort By:
Pageof 37
ACS Omega|August 19, 2022
Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike InhibitorsAna C Puhl, Melina Mottin, Carolina Q Sacramento, et al.
Journal of Medicinal Chemistry|November 3, 2023
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic AgentsPasquale Linciano, Antonio Quotadamo, Rosaria Luciani, et al.
ACS Infectious Diseases|May 24, 2022
Pyronaridine Protects against SARS-CoV-2 Infection in MouseAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Scientific Reports|February 18, 2018
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanKLaurent R Chiarelli, Giorgia Mori, Beatrice Silvia Orena, et al.
Scientific Reports|November 29, 2019
A diarylamine derived from anthranilic acid inhibits ZIKV replicationSuely Silva, Jacqueline Farinha Shimizu, Débora Moraes de Oliveira, et al.
ACS Infectious Diseases|March 20, 2025
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 CompoundDeborah Recchia, Giovanni Stelitano, Anna Egorova, et al.
ACS Omega|September 13, 2022
Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected MiceAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
Bioorganic Chemistry|February 6, 2022
Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteinsMelina Mottin, Lindsay K Caesar, David Brodsky, et al.
Cell Chemical Biology|November 13, 2019
Antitubercular Triazines: Optimization and Intrabacterial MetabolismXin Wang, Daigo Inoyama, Riccardo Russo, et al.
Pageof 37